Unlocking Clinical Insights: The Role of MRD as an Endpoint, Technologies, & Regulatory Perspectives
- How can MRD serve as a reliable surrogate endpoint to predict long-term clinical benefits in hematologic malignancies?
- What are the latest advancements in detection technologies that can enhance the sensitivity and reproducibility of MRD measurement?
- How are regulatory agencies evolving their frameworks to accept MRD as endpoint in clinical trials?